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ABSTRACT
Background: Myalgia is the most common cause of Temporomandibular Disorders (TMDs) pain, which has a dull and
mild character. In some patients with high somatization, it can present itself as severe pain, which can complicate the
treatment. Additional pharmacological treatment may thus be needed. Case Report: Two female patients came with
similar symptoms but different pain intensities. The first patient had a high intensity of pain, which became severe during
examination. The second patient had more complaints but showed typical symptoms of myalgia. Both received
physiotherapy sessions, but for the first patient, we added analgesics to help the patient endure physiotherapy.
Conclusion: Additional pharmacological treatments, especially analgesics, can be used in helping myalgia patients with
high somatization to undergo physiotherapy.
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Background
Temporomandibular disorders (TMD) are a group
of conditions affecting the masticatory muscles, the
temporomandibular joints (TMJ), or both. Pain, functional
limitation, and joint sounds are the cardinal signs for
which patients seek care.1 Myalgia is the most common
cause of pain in patients with Temporomandibular
disorders (TMD). It presents itself as dull, mild, remitting,
self-limiting, and fluctuating pain.1 A report from a TMD
specialty clinic showed that 55% of their patients met the
criteria of having chronic myofascial pain or myalgia.2
Physiotherapy is the treatment of choice for
myofascial pain treatment, because it relieves
musculoskeletal pain, restores normal function by
coordinating muscle activity, and promotes the repair and
regeneration of tissue.3 The use of pharmacological
treatments in accompanying physiotherapy is often used,
though there is no guidance on when and how to deliver
the mode of treatment.4 This case report describes two
cases of patients with myofascial pain complaint who
underwent physical therapy with and without the addition
of pharmacological treatment.
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Case Report 1
Male patient of 40 years of age complained of clicking
sound with sharp pain on both TMJs. Pain was felt as sharp
following clicking sound, and there was also tense feeling
in the cheek area and around the ears especially after every
meal. Patient scored his pain as 8 on VAS scale. Patient
was afraid to move his jaw due to the pain. Patient did not
have any systemic complaints. During examination,
palpation on the masseter and palpation area provoked his
pain complaint (Fig. 1). There was a limitation on maximal
mouth opening (28 mm), and patient refused to open wider
as he felt a severe pain around the cheek area. Clicking
was detected on both joints on both mouth opening and
closing movement. The diagnosis of this case was myalgia
with myogenous limited mouth opening and anterior disc
displacement with reduction on both joints. The treatment
approach was divided into two parts, which are (1)
counselling on the etiology of pain and clicking sound, and
(2) physical therapy which consisted of massage and
mobilization therapy. Patient was instructed to take
analgesics on the day of the first appointment of physical
therapy. The additional medication was also given on the
second appointment of physical therapy as patient was still
afraid of pain on jaw movement. After the third
appointment, patient could do the physical therapy on his
own which increased his mouth opening to 40 mm without
feeling any pain. Patient was no longer disturbed by his
joint sound.
Case Report 2
Female of 40 years of age came with a blocked feeling
on mouth opening and pain around right cheek area. Pain
started around 5 years ago on the right ear, and felt like a
sharp pain (VAS scale 2) which increased in intensity on
chewing and talking. Patient also complained of
intermittent blockage on jaw movement which started
around 1 year ago. Patient did not have any systemic
complaints. Clinical examination revealed painless mouth
opening of 29 mm, but patient could open until 45 mm
when instructed. Palpation on the right masseter provoked
her pain complaint (VAS scale 4). Palpation on the right
TMJ did not cause any pain, but crepitus sound was
detected during opening and closing jaw movement. The
diagnosis of this case was myalgia with myogenous limited
mouth opening and a possibility of arthrosis on the right
TMJ. The treatment approach was divided into two parts,
which are (1) counselling on the etiology of pain and
movement limitation, and (2) physical therapy which
consisted of massage and mobilization therapy. Patient was
not given any medication on all of her physical therapy
appointments. After two physical therapy sessions, patient
could already open until 40 mm, and her pain was
decreased (VAS scale 2). Patient was instructed to come
every 6 months to evaluate her right joint condition.
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Figure 1. Palpation was done on masseter area according to Diagnostic Criteria of 
Temporomandibula (DC/TMD) protocol 
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Discussion
This report discussed about two patients with the
same pain diagnosis but received different treatment. The
first patient was given additional medication before
underwent his physiotherapy appointments, while the
other was not given any. The exercises which are
commonly included in myofascial physiotherapy are
muscle massage, muscle stretching, gentle isometric
tension exercises against resistance, guided opening and
closing movements, correction of body posture, and
relaxation techniques.5,6 Based on a clinical study, 85%
of myofascial pain patients no longer experienced pain
and 60% had improved mouth function in 6-month
follow-up after physiotherapy.4 However pharma-
cological treatment is still recommended for initial use in
myofascial pain treatment, especially in combination with
physiotherapy.4
Medications that are widely used are analgesics, non-
steroid anti-inflammatory drugs (NSAIDs), muscle
relaxants, benzodiazepines, and low-dose antidepressants.
Questions then arise whether medications add value to
the overall success of pain management by means of
physiotherapy and what the rationale is for giving such
medications. In many chronic pain cases, patients will
either be prescribed analgesics or have already been
taking them. Both non-opioid analgesics and NSAIDs act
by inhibiting prostaglandin synthesis and they are
effective in reducing pain and tension feeling
accompanying chronic pain patients.7 NSAIDs are only
given if inflammation is the dominant component in the
clinical finding.
Since analgesics are only prophylactic drugs, they
have to be accompanied with a more definite treatment
such as physiotherapy. In fact, many combine both
approaches, as to increase the patient’s adaptation and
adherence to the physiotherapy treatment. Clinical
reasoning to give additional analgesics in combination
with physiotherapy in this case basically depends on
patients’ condition. The first patient in this case report
complained of high intensity of pain (VAS Scale 8),
although on examination it revealed that it was pain of
myogenous origin.1 This may indicate that patient had
high somatization which can complicate treatments,
especially in physiotherapy where pain is expected to be
provoked during certain movements.
Other medications can be used, though it is not
commonly practiced in cases such as the two presented in
this case report. For example, muscle relaxants affect
skeletal muscle function and are used to decrease muscle
tone. One of the medications, Cyclobenzaprine, has been
used widely in fibromyalgia and tension-type headache
treatment.1 The use of muscle relaxant in combination
with physiotherapy was, however, lacking evidence.8
Other medication, Benzodiazepines, possess sedative,
hypnotic, anxiolytic, anticonvulsant, analgesic, muscle
relaxant, and amnesic actions, which are useful in chronic
myofascial patients with a high psychological component
and/or sleep problems.9,10
A study by De Nucci et al. on the efficacy of
Triazolam in TMD patients’ pain management showed
that there is a significant improvement in sleep quality
and alterations in patients’ sleep architecture.9
Nevertheless, they did not find any improvement in
patients’ pain complaint as measured by muscle palpation
with an algometer, in scales for sensory intensity and the
affective component of pain, or in daily pain diaries. The
study also recommended the use of benzodiazepines for
myofascial pain patients to be restricted to 2 to 4 weeks,
due to many side effects, dependence risk, and
withdrawal syndrome. In the early years, antidepressants
were chosen because they were thought to relieve the
depression component of chronic pain. Although it is well
known that relieving depression is likely to decrease pain,
some antidepressants appear to have analgesic properties
of its own.7,11,12 Both benzodiazepines and anti-
depressants are not commonly used in combination with
physical therapy and there are no studies which observe
the combination efficacy.
Conclusion
There is not a single study that directly observes the
efficacy of additional pharmacological therapy to
physiotherapy in chronic myofascial pain cases. Most of
the medications were used when physiotherapy was not
a treatment option of pain management. They were also
used in a short term and mainly as a prophylactic
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treatment. However, analgesics are often used in the initial
phase of physiotherapy to help patient adapting to the
exercise.
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